CAR-M

Chimeric antigen receptor monocytes · Carisma Therapeutics Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAR-M, covering 2024-12-19 to 2024-12-19. Get the full timeline:

Most recent: Clinical Trial Update: CAR-monocytes for the Treatment of HER2 Overexpressing Solid Tumors [Phase 1]